StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ELAN

Elanco Animal Health Incorporated

ELAN NYSE Pharmaceutical Preparations EDGAR ↗
$25.72
-0.74 -2.80%

Key statistics

from XBRL data in SEC filings
Market cap
$12.8B
Revenue (TTM)
$4.89B
Net income (TTM)
-$242M
EPS (TTM)
$-0.49
P/E ratio
Dividend yield
Free cash flow
$284M
Cash
$428M
Total assets
$13.2B
Gross margin
55.1%
52-week range
$13.76 – $27.72

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results May 27, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release) Feb 24, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Exit or disposal costs; Regulation FD disclosure Dec 9, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Entered a material agreement; Took on a direct financial obligation Nov 3, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jun 26, 2025 8-K Director or officer change; Regulation FD disclosure May 28, 2025 8-K Shareholder vote results May 21, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Director or officer change; Regulation FD disclosure Mar 17, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Director or officer change; Regulation FD disclosure Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Regulation FD disclosure Oct 16, 2024 8-K Entered a material agreement; Took on a direct financial obligation Aug 13, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Completed an acquisition or disposition; Regulation FD disclosure Jul 9, 2024 8-K Entered a material agreement; Took on a direct financial obligation Jul 3, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 4, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Apr 1, 2024 10-K Fiscal year ended 2023-12-31 Feb 26, 2024 8-K Results of operations (earnings release); Exit or disposal costs Feb 26, 2024 8-K Entered a material agreement; Regulation FD disclosure Feb 5, 2024 8-K Regulation FD disclosure Jan 8, 2024 8-K Regulation FD disclosure Jan 2, 2024 10-Q Quarter ended 2023-09-30 Nov 7, 2023